Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

TDH Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 1
Lead investments 0
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Therapeutics
  • Medical
  • Biotechnology
  • Health Care
Summary

The venture was found in North America in United States. The leading representative office of defined VC is situated in the Radnor.

The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2006. The higher amount of exits for fund were in 2013. The usual things for fund are deals in the range of 1 - 5 millions dollars.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the TDH Capital, startups are often financed by BioAdvance. The meaningful sponsors for the fund in investment in the same round are Osage Venture Partners, BioAdvance, Ben Franklin Technology Partners of Southeastern Pennsylvania. In the next rounds fund is usually obtained by Vivo Capital, Palo Alto Investors, BioAdvance.

Among the most successful fund investment fields, there are Health Care, Therapeutics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Ceptaris Therapeutics For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of TDH Capital:
Typical Co-investors
TDH Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after TDH Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Andrew Carter Capital Dallas, Texas, United States
Asigin Research institute Ltd. Japan, Tochigi Prefecture, Utsunomiya
Asset Management Associates California, Palo Alto, United States
Boehringer Ingelheim Germany, Ingelheim Am Rhein, Rheinland-Pfalz
BSKG Holdings -
Debiopharm Innovation Fund Lausanne, Switzerland, Vaud
FLAG Capital Management Connecticut, Stamford, United States
Grameen Foundation District of Columbia, United States, Washington
Growth Finance Fund -
Hattery California, San Francisco, United States
Lewis & Clark AgriFood Missouri, St Louis, United States
MX Capital -
Poly Capital China, Guangdong, Guangzhou
QUI! GROUP Genova, Italy, Liguria
Shikong Wuxing China, Shanghai
Sirios Capital Management Boston, Massachusetts, United States
StratMinds California, San Francisco, United States
TNB Ventures Central, Central Region, Singapore
Visit Intelligence Oy Finland, Parainen, Southwest Finland
WIV Wein International Germany, Rheinland-Pfalz, Rhineland-Palatinate

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ceptaris Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$4M14 Nov 2006 Pennsylvania, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent TDH Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 4M
Peak activity year 2006
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ceptaris Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$4M14 Nov 2006 Pennsylvania, United States
Crunchbase icon

Content report

The following text will be sent to our editors: